Cumberland Pharmaceuticals Surges Over 36% on Apotex Deal
Cumberland Pharmaceuticals Inc. (CPIX.US) traded at $4.17, up +36.72% intraday, posting a sharp single-session gain.
Cumberland Pharmaceuticals, a specialty pharmaceutical company focused on hospital and acute care markets, surged after Apotex announced a strategic transaction with the company. Apotex, one of the world's largest generic drug manufacturers, confirmed the deal, which the market interpreted as a validation of Cumberland's core asset value, drawing strong buying interest and driving a significant intraday rally.
